Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Crossover Experiments01:16

Crossover Experiments

3.4K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
3.4K
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

419
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
419
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

357
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
357
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

407
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
407
Bioequivalence: Overview01:16

Bioequivalence: Overview

2.2K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
2.2K
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

430
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
430

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trends and projections in the burden of congenital heart disease among children under 5 years, 1990-2035.

Translational pediatrics·2026
Same author

Long-term burden, trends, and inequality of lower respiratory infections attributable to <i>Mycoplasma pneumoniae</i> among children and adolescents in low- and middle-income countries, 1990-2023: a Global Burden of Disease Study 2023 analysis.

Translational pediatrics·2026
Same author

Identification of Major Depressive Disorder Using Multiple Functional Connection Patterns.

CNS neuroscience & therapeutics·2026
Same author

A retrospective cohort study on clinical features of foreign bodies in the gastrointestinal tract of children-emergency data from a pediatric regional medical center in eastern China.

Translational pediatrics·2026
Same author

Nursing management of deep vein thrombosis in children: a narrative review of challenges, evidence-based strategies, and systematic pathways.

Translational pediatrics·2026
Same author

Spatial characterization of skin lesions in discoid and systemic lupus erythematosus.

Nature communications·2026

Related Experiment Video

Updated: May 4, 2026

Frequency and Distribution of Crossovers in Caenorhabditis elegans Meiosis by SNP Genotyping using Real-time PCR
06:18

Frequency and Distribution of Crossovers in Caenorhabditis elegans Meiosis by SNP Genotyping using Real-time PCR

Published on: July 11, 2025

933

Influence analysis on crossover design experiment in bioequivalence studies.

Yufen Huang1, Bo-Shiang Ke

  • 1Department of Mathematics, National Chung Cheng University, Chia-Yi, Taiwan.

Pharmaceutical Statistics
|December 17, 2013
PubMed
Summary

Outlying observations can impact bioequivalence study decisions. This study introduces new influence functions using perturbation theory to reliably identify outliers in crossover designs, especially for small sample sizes.

Keywords:
bioequivalenceinfluence functionsperturbation

More Related Videos

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
20:24

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study

Published on: January 31, 2014

16.3K
Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

840

Related Experiment Videos

Last Updated: May 4, 2026

Frequency and Distribution of Crossovers in Caenorhabditis elegans Meiosis by SNP Genotyping using Real-time PCR
06:18

Frequency and Distribution of Crossovers in Caenorhabditis elegans Meiosis by SNP Genotyping using Real-time PCR

Published on: July 11, 2025

933
Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
20:24

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study

Published on: January 31, 2014

16.3K
Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

840

Area of Science:

  • Biostatistics
  • Pharmacokinetics
  • Clinical Trial Design

Background:

  • Crossover designs are standard in bioequivalence studies.
  • Outlying observations can compromise study validity and lead to incorrect bioequivalence conclusions.
  • Existing methods for outlier detection have limitations.

Purpose of the Study:

  • To develop and evaluate novel influence functions for detecting aberrant observations in crossover designs.
  • To compare the proposed method with existing techniques for outlier analysis.
  • To provide a robust tool for sensitivity analysis in bioequivalence studies.

Main Methods:

  • Application of perturbation theory and Hampel's scheme to derive influence functions.
  • Comparative analysis of the proposed influence functions against Chow and Tse's methods.
  • Illustration using two real-world bioequivalence study datasets.

Main Results:

  • The developed influence functions effectively identify outlier and influential observations.
  • The proposed method demonstrates superior performance in outlier detection.
  • The approach is particularly suitable for small sample size crossover designs.

Conclusions:

  • The novel influence functions offer a reliable alternative for outlier detection in bioequivalence crossover studies.
  • This method enhances the robustness of bioequivalence assessments by mitigating the impact of aberrant data.
  • The findings support the use of this technique in regulatory bioequivalence evaluations.